SAN DIEGO (PRWEB)
September 09, 2022

Debut, an innovation company at the forefront of advanced biomanufacturing and consumer products, announced today a rebrand and new vision for next-generation consumer products by way of vertically integrated biology. Over the past three years, Debut has built the infrastructure to quickly move from ingredient discovery to sustainable consumer products. Debut uses breakthrough biotechnology and creativity to build big businesses that will put humanity ahead in an ever-changing world.

Traditional synthetic biology companies have pursued horizontal approaches, licensing, and low-margin B2B business structures that create unpredictable revenue streams and difficulties in penetrating global supply chains. The result is an inability to deliver products containing better ingredients that consumers demand, move past R&D, and generate the revenue streams required for sustained growth and longevity.

Debut’s proprietary Bio2Consumer™ platform enables the company to move rapidly from ingredient discovery to personal care and nutrition consumer products. The platform enables high throughput ingredient discovery, rapid testing, biomanufacturing, product formulation, pre-clinical testing, and on-site scaled manufacturing to deliver high-performing, natural, and sustainable consumer products. The result is a 98% reduction in testing cost and a 50% reduction in time-to-market compared to traditional horizontal companies.

According to a recent report, more than 58% of consumers across all generations are willing to spend more on sustainably manufactured products. As they become a larger buying force in the market, 90% of Gen X consumers would be willing to spend more for these types of products. With Debut’s approach, consumers need not choose between sustainability, performance, and cost.

“Our rebrand represents the next stage in synthetic biology. For synthetic biology to have a true impact on humanity, it needs to be commercialized, integrated into global supply chains, and ultimately embraced by consumers,” said Debut CEO Joshua Britton. “Consumers have been subjected to the same ingredients for years and typical marketing and greenwashing tactics have become the norm for larger, multinational corporations. It’s time to deliver high-performing products in high demand in multiple verticals. Our vertically integrated approach allows us to make an impact in a way that no other synthetic biology company has been able to achieve. We are creating consumer brands that will impact our routines from the time we wake up, get ready for work, and feed our animals to when we eat, exercise, and sleep. We see a future where synthetic biology-driven products are a norm for society and petroleum-derived products are long gone.”

Debut will launch its first brand next year and has the next set of high-growth brands in development. The company is creating sustainable and clinically proven consumer products that will become the next generation of household name brands, powered by Debut’s proprietary actives. The company can achieve this through the integration of next-generation biomanufacturing technology with a human-centered design approach that delivers efficiency to market and a real impact on consumers’ health and well-being. Joshua states, “We are eying significant US household penetration targets and the globalization of synthetic biology driven products. Think about what Unilever did during the chemical revolution in 1930 — we are doing that with biology.”

The company is currently building end-to-end manufacturing infrastructure and will continue to expand its Innovation Labs in San Diego, New York, Los Angeles, and Atlanta over the next several years. To learn more about Debut and its vertically integrated approach, visit http://www.debutbiotech.com.

Debut

Debut uses science, strategy, and creativity to build big businesses that put humanity ahead. Powered by breakthrough biotechnology and human-centered brand innovation, our integrated creation model sets the pace for an ever-changing world. For more information see https://www.debutbiotech.com/.

Share article on social media or email: